Bioextrax AB (publ)
Stockholm Stock Exchange BIOEX.ST
Bioextrax AB (publ) EBITDA for the year ending December 31, 2023: USD -2.04 M
Bioextrax AB (publ) EBITDA is USD -2.04 M for the year ending December 31, 2023, a -17.31% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Bioextrax AB (publ) EBITDA for the year ending December 31, 2022 was USD -1.74 M, a -55.00% change year over year.
-
Bioextrax AB (publ) EBITDA for the year ending December 31, 2021 was USD -1.12 M, a -71.35% change year over year.
-
Bioextrax AB (publ) EBITDA for the year ending December 31, 2020 was USD -654.04 K, a -227.71% change year over year.
-
Bioextrax AB (publ) EBITDA for the year ending December 31, 2019 was USD -199.58 K, a -107.60% change year over year.
Key data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Market news
Loading...
Stockholm Stock Exchange: BIOEX.ST
| CEO | Mr. Edvard Hall |
| IPO Date | April 28, 2020 |
| Location | Sweden |
| Headquarters | Skiffervägen 76 |
| Employees | 13 |
| Sector | Health Care |
| Industries | |
Description
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email